Adverse Event Reporting News - Lilly settles hundreds of Zyprexa lawsuits
Lilly settled an additional 900 product liability lawsuits involving its top-selling drug, the anti-psychotic Zyprexa.
Lilly has settled roughly 28,500 product liability claims involving Zyprexa over the past two years. In June 2005, the company settled 8,000 claims for $690 million. This past January, it settled more than 18,000 for roughly $500 million.
Most of the claims center on allegations that Zyprexa causes diabetes or high blood sugar and that labels on the drug failed to adequately warn users of the risks.
The company was scheduled to go to trial July 9 in federal court for four Zyprexa claims, but those cases are part of the latest settlement, Lemons said.
Related Results
Injectable ZyprexaZyprexa WarningZyprexa filingZyprexa unveiledTexas depresses Zyprexa
Lilly still faces product liability lawsuits from roughly 750 patients.
COPYRIGHT 2007 Washington Information Source, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
